Calcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertension

被引:48
作者
Pedrinelli, R [1 ]
Dell'Omo, G [1 ]
Mariani, M [1 ]
机构
[1] Univ Pisa, Dipartimento Cardiotorac, I-56100 Pisa, Italy
关键词
calcium channel blockers; postural vasoconstriction; skin blood flow; hypertension; essential; angiotensin converting enzyme inhibitors;
D O I
10.1038/sj.jhh.1001201
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Treatment with calcium channel blocker (CCB)s, dihydropyridines and others, is frequently complicated by dependent oedema in the absence of sodium retention or cardiac failure, a bothersome side effect of unclear aetiology, The present paper reviews our own and other work dealing with the antagonism exerted by such drugs on postural vasoconstriction, a mechanism triggered by limb venous congestion during orthostasis and controlled through a local sympathetic axo-axonic reflex and increased myogenic tone in response to changes in transmural pressure. By stabilising capillary pressure, postural vasoconstriction counteracts fluid hyperfiltration consequent to gravitational stimuli, and consistent evidence shows attenuation of this response by L-type calcium channel blockers. Interference with the postural reflex control of skin blood flow may therefore contribute to dependent oedema, although cannot entirely explain its development. Attenuation of postural vasoconstriction may amplify the fluid hyperfiltration induced by CCBs through other mechanisms, such as imbalanced intracapillary pressure or enhanced vascular permeability, which are the main factors determining net fluid filtration into the interstitial compartment.
引用
收藏
页码:455 / 461
页数:7
相关论文
共 59 条
[1]  
ABRAMS WB, 1984, FED PROC, V43, P1314
[2]   THE ALPHA-1-ADRENOCEPTOR ANTAGONIST PROFILE OF DOXAZOSIN - PRECLINICAL PHARMACOLOGY [J].
ALABASTER, VA ;
DAVEY, MJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 :S9-S17
[3]   The cutaneous microcirculation: Ultrastructure and microanatomical organization [J].
Braverman, IM .
MICROCIRCULATION, 1997, 4 (03) :329-340
[4]   PHARMACOLOGIC PROFILE OF AMLODIPINE [J].
BURGES, RA ;
DODD, MG ;
GARDINER, DG .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (17) :I10-I20
[5]   Voltage-gated T-type Ca2+ channels and heart failure [J].
Clozel, JP ;
Ertel, EA ;
Ertel, SI .
PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1999, 111 (05) :429-437
[6]   AN OVERVIEW OF THE CLINICAL-PHARMACOLOGY OF ENALAPRIL [J].
DAVIES, RO ;
GOMEZ, HJ ;
IRVIN, JD ;
WALKER, JF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 :S215-S229
[7]   Signaling mechanisms underlying the vascular myogenic response [J].
Davis, MJ ;
Hill, MA .
PHYSIOLOGICAL REVIEWS, 1999, 79 (02) :387-423
[8]   SPECIFIC PHARMACOLOGY OF CALCIUM IN MYOCARDIUM, CARDIAC-PACEMAKERS, AND VASCULAR SMOOTH-MUSCLE [J].
FLECKENSTEIN, A .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1977, 17 :149-166
[9]   CALCIUM-ANTAGONISTS PREFERENTIALLY DILATE PREGLOMERULAR VESSELS OF HYDRONEPHROTIC KIDNEY [J].
FLEMING, JT ;
PAREKH, N ;
STEINHAUSEN, M .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 253 (06) :F1157-F1163
[10]   PROPTOSIS AND PERIORBITAL EDEMA DUE TO DILTIAZEM TREATMENT [J].
FRIEDLAND, S ;
KAPLAN, S ;
LAHAV, M ;
SHAPIRO, A .
ARCHIVES OF OPHTHALMOLOGY, 1993, 111 (08) :1027-1028